Use Of Diabetes Drug Linked To Higher Risk Of Bone Fractures [news]
The findings of a study published recently in the open access journal, PLoS Medicine, suggest that there is a link between a type of drug introduced in the 1990s to treat type 2 diabetes (thiazolidinediones) and bone fracture.
The authors categorized 1,819 individuals aged 40 years or older who had a recorded bone fracture and who had been prescribed a thiazolidinedione at least once. They conducted a self-controlled case-series study. They evaluated how often an event, such as bone fracture, occurs in a population of people during the time when they are taking a particular medication which is in this case a thiazolidinedione drug. They then compared it against the period when those individuals are not taking the medication.